Literature DB >> 12402981

Cell-to-Cell adhesion via intercellular adhesion molecule-1 and leukocyte function-associated antigen-1 pathway is involved in 1alpha,25(OH)2D3, PTH and IL-1alpha-induced osteoclast differentiation and bone resorption.

Yosuke Okada1, Isao Morimoto, Kazumi Ura, Kenichi Watanabe, Sumiya Eto, Masayoshi Kumegawa, Lawrence Raisz, Carol Pilbeam, Yoshiya Tanaka.   

Abstract

Cell-to-cell interaction is required for the differentiation of osteoclast precursors as well as for osteoclast function. The present study was undertaken to determine whether 1,25 dihydroxyvitamin D3 (1,25D), PTH, IL-1alpha and PGE2 depend on cell-to-cell interactions through the intercellular adhesion molecule (ICAM)-1/leukocyte function-associated antigen (LFA)-1 pathway in osteoclast formation and bone resorption. We found that mouse osteoblasts expressed ICAM-1 and that the expression was increased by treatment with PTH, IL-1alpha or 1,25D, but not by PGE2. In resorption assays measuring either 45Ca release from bone organ cultures or pit formation in bone cell cultures, 1,25D-, PTH- and IL-1alpha-stimulated resorption was inhibited by anti-ICAM-1 monoclonal antibody (mAb) and/or anti-LFA-1 mAb, while basal and PGE2-stimulated bone resorbing activities were not affected by these mAbs. Furthermore, in a mouse bone marrow culture system, stimulation of osteoclast-like (OCL) cell formation by 1,25D (10 nM), PTH (10 ng/ml) or IL-1alpha (10 ng/ml) was inhibited by the addition of anti-ICAM-1 mAb and/or anti-LFA-1 mAb. In a coculture system of murine spleen cells and osteoblasts, the ICAM-1/LFA-1 interaction was also involved in 1,25D-, PTH- and IL-1alpha-stimulated TRAP-positive MNC formation. However, anti-ICAM-1 mAb and anti-LFA-1 mAb did not alter either 1,25D- or PTH-stimulated receptor activator of NF-kappaB ligand (RANKL) mRNA transcription in bone marrow cultures. Taken together, we here propose that ICAM-1-mediated cell-to-cell adhesion of osteoblasts and osteoclast precursors is involved in RANKL-dependent osteoclast maturation stimulated by 1,25D, PTH, and IL-1alpha.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12402981     DOI: 10.1507/endocrj.49.483

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  15 in total

1.  Osteoclastogenic activity and RANKL expression are inhibited in osteoblastic cells expressing constitutively active Gα(12) or constitutively active RhoA.

Authors:  Jun Wang; Paula H Stern
Journal:  J Cell Biochem       Date:  2010-12-15       Impact factor: 4.429

Review 2.  RNA therapeutics targeting osteoclast-mediated excessive bone resorption.

Authors:  Yuwei Wang; David W Grainger
Journal:  Adv Drug Deliv Rev       Date:  2011-09-10       Impact factor: 15.470

3.  Eosinophil chemotactic factor-L (ECF-L) enhances osteoclast formation by increasing in osteoclast precursors expression of LFA-1 and ICAM-1.

Authors:  Veronica Garcia-Palacios; Ho Yeon Chung; Sun Jin Choi; Aliye Sarmasik; Noriyoshi Kurihara; Jun Won Lee; Deborah L Galson; Robert Collins; G David Roodman
Journal:  Bone       Date:  2006-09-25       Impact factor: 4.398

Review 4.  Extracellular Vesicle-Mediated Bone Remodeling and Bone Metastasis: Implications in Prostate Cancer.

Authors:  Kalyani C Patil; Carolina Soekmadji
Journal:  Subcell Biochem       Date:  2021

5.  Osteoblastic NF-κB pathway is involved in 1α, 25(OH)2D3-induced osteoclast-like cells formation in vitro.

Authors:  Lin Cong; Chaoyi Zhang; Guanjun Tu
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

6.  Relationships between inflammation, immune activation, and bone health among HIV-infected adults on stable antiretroviral therapy.

Authors:  Kristine M Erlandson; Maryann OʼRiordan; Danielle Labbato; Grace A McComsey
Journal:  J Acquir Immune Defic Syndr       Date:  2014-03-01       Impact factor: 3.731

7.  Plasma Sclerostin in HIV-Infected Adults on Effective Antiretroviral Therapy.

Authors:  Kristine M Erlandson; MaryAnn O'Riordan; Corrilynn O Hileman; Eric Rapaport; Danielle Labbato; Thomas B Campbell; Grace A McComsey
Journal:  AIDS Res Hum Retroviruses       Date:  2015-05-27       Impact factor: 2.205

8.  Effects of IL-23 and IL-27 on osteoblasts and osteoclasts: inhibitory effects on osteoclast differentiation.

Authors:  Sadahiro Kamiya; Chika Nakamura; Takeshi Fukawa; Katsuhiro Ono; Toshiyuki Ohwaki; Takayuki Yoshimoto; Seiki Wada
Journal:  J Bone Miner Metab       Date:  2007-08-25       Impact factor: 2.626

9.  An active role for soluble and membrane intercellular adhesion molecule-1 in osteoclast activity in vitro.

Authors:  Julio C Fernandes; Qin Shi; Mohamed Benderdour; Daniel Lajeunesse; Patrick Lavigne
Journal:  J Bone Miner Metab       Date:  2008-11-01       Impact factor: 2.626

10.  BISPHOSPHONATES FOR THE TREATMENT OF CALCITRIOL-INDUCED HYPERCALCEMIA.

Authors:  Roselyn Cristelle Isidro Mateo; Ricardo Ortiz; Harold Noah Rosen
Journal:  AACE Clin Case Rep       Date:  2019-06-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.